Clinical Trial

Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study was to determine the efficacy and safety of toripalimab combined with radiotherapy in the treatment of oligometastatic nasopharyngeal carcinoma
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-11-23; most recent amendment 2025-07-11.
Status change: Not Yet Recruiting → Recruiting 2024-02-26
Trial Details
NCT Number NCT05147844
Lead Sponsor Xinqiao Hospital of Chongqing
Collaborators: Southwest Hospital, China, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Chongqing University Cancer Hospital
Conditions Nasopharyngeal Carcinoma
Enrollment 40 participants
Start Date 2022-03-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-14